July 26th, 2016

Improving Lives Through Innovation: Meet the Man Who’s Inventing New Ways to Help Millions of Diabetes Patients

By Ginny Graves

Adrian Chernoff

Chernoff is Johnson & Johnson’s new Worldwide Vice President for Research & Development and Innovation in Diabetes Care

What do Disney theme park rides, rubber bands, NASA medical robots and electric vehicles all have in common?

Answer: The man who’s either helped invent or develop them.

Meet Adrian Chernoff, Johnson & Johnson’s new Worldwide Vice President for Research & Development and Innovation in Diabetes Care, who’s tasked with applying his prodigious inventiveness to designing simpler and more efficient insulin-delivery and glucose management systems.

It’s a need that’s acute: Fully half of all people with diabetes don’t take their medications as often as they should. And with nearly 30 million people in the U.S. suffering from diabetes—and 422 million worldwide—Chernoff’s innovation prowess has the potential to revolutionize their lives.

So we sat down with Chernoff, 44, to find out where his creative spark comes from—and how he plans to spin that into innovative, yet practical, solutions for people with diabetes.

When did you first realize you had a knack for inventing things?
Adrian Chernoff:
I started sketching and drawing ideas when I was 5 or 6. I remember looking at the batteries that went into one of my toys and thinking: Why is it shaped like that?

Read More

July 22nd, 2016

3 High-Tech Healthcare Innovations That Could Improve Your Life

By Stuart McGuigan, Vice President, Chief Information Officer, Johnson & Johnson


People with diabetes can now monitor their blood glucose levels using a mobile app

Technology is transforming just about every industry—and healthcare is one of the most exciting new frontiers. If your current digital healthcare experience is a fun fitness app on your smartphone, you haven’t seen anything yet.

Unprecedented opportunities exist for technology to make a real difference in the health of people around the world. And, in doing so, technology is also poised to help stem rising healthcare costs.

I recently had the opportunity to speak at the Global ICT Summit in Tokyo, an annual event sponsored by Nikkei Inc. and Japan’s Ministry of Internal Affairs and Communications that focuses on new technology trends. Japan was a fitting setting for a discussion about healthcare technology, given that its citizens enjoy the world’s longest life expectancy.

But as senior citizens around the world work to stay healthy and active, many of them must also manage chronic diseases. In the U.S. alone, 86% of all healthcare spending in 2010 went to people with one or more chronic medical conditions, according to the Centers for Disease Control and Prevention.

So finding better and more cost-efficient ways to deliver and manage those medical resources is a key need worldwide—and a top focus area at Johnson & Johnson.

Read More

July 21st, 2016

Home Away From Home: A New USO Center Opens at Newark Liberty International Airport

By Patrick Schumaker

Newark Airport Sign
Between flight delays, long TSA lines and jetlagged travelers rushing to catch connecting flights, most airports don’t exactly have a reputation for being the most warm and welcoming of places.

But that’s about to change for military service members visiting New Jersey’s Newark Liberty International Airport, whether they’re preparing to deploy or waiting for a loved one to arrive home.

On July 21, the USO, with support from Johnson & Johnson, opened its newest comfort center for active service members and their families at the airport’s Terminal B. With the help of volunteers, the center is expected to eventually be open 24 hours a day, seven days a week, and offer everything from refreshments to a computer station and a children’s play area.

Caring for Those Who Care for Their Country
Johnson & Johnson is the Official Healthcare Partner of the USO, so helping the new comfort center open its doors is just one way that the company has shown a commitment to improving the wellbeing of American service members and their families.

Among other programs, the company has also provided support for the USO Warrior and Family Center in Bethesda, Maryland, which hosts service members being treated at the nearby Walter Reed National Military Medical Center, along with their family members.

Read More

July 20th, 2016

mhNOW: How Entrepreneurs, Companies and Organizations Are Coming Together to Improve Mental Health

By Bonnie Petrauskas, Executive Director, Worldwide Corporate Contributions


BasicNeeds, an mhNOW partner, organizes routine meetings with community members in Ghana to help address mental health needs

How many times have you have heard the phrase “mind over matter”?

It’s an expression that’s often used–even overused–in situations where people doubt their ability to achieve a goal, or perhaps experience physical pain.

Although this saying is intended to be a motivating force, it can be anything but that for people struggling with mental health conditions. In a mind-over-matter world, these people often hold back from seeking help for a variety of reasons, including stigma, denial and poor access to care.

This hesitancy to speak out about mental health is not surprising, given society’s tendency to assume that people can overcome mental barriers by simply trying harder. To put that into perspective, we would never consider challenging someone with a broken leg to climb a mountain.

Some disabilities aren’t easily visible–and mental health challenges can be formidable obstacles.

Fortunately, mental health advocates are gaining momentum, and the availability of robust scientific data is helping to elevate this overlooked challenge onto the global stage. In fact, mental health has been recognized as part of the United Nations’ Sustainable Development Goals as an essential ingredient to achieving healthy lives and well-being for all.

Read More

July 20th, 2016

2016 International AIDS Conference: What It Will Take to Achieve an HIV-Free World

By Jaak Peeters, Head of Johnson & Johnson’s Global Public Health organization

HIV Free World
Johnson & Johnson’s global public health strategy includes efforts to ensure that adolescents living in regions like Sub-Saharan Africa stay HIV-free

Sixteen years may not seem like a long time, but to the global community fighting HIV/AIDS, profound changes have occurred since the last time the International AIDS Society hosted its biennial conference in Durban, South Africa.

Looking back at the 2000 Durban conference, it’s easy to forget how different things were then. Until that point, an AIDS conference had never been held in a developing country, major governments were still denying the connection between HIV and AIDS, and millions of people lacked access to lifesaving treatments.

Ahead of the conference, more than 5,000 scientists came together to sign the “Durban Declaration,” which confirmed the overwhelming scientific evidence about the causes of AIDS.

This week, nearly two decades later, we are back in Durban for the 21st International AIDS Conference to build on our shared accomplishments and address new obstacles.

Our tools for preventing and treating the disease are more effective than ever: Mother-to-child transmission of HIV in Sub-Saharan Africa is nearly eliminated, anti-retroviral therapies allow people with HIV to live long and productive lives, and we are moving closer to developing a viable HIV vaccine.

Read More

July 19th, 2016

What You Need to Know About Johnson & Johnson’s 2016 Second-Quarter Earnings

From pharmaceutical to medical device sales, Johnson & Johnson reported growth in the second quarter of 2016, with total sales coming in at $18.5 billion.

For a deeper-dive look at the company’s second-quarter earnings, check out this handy infographic, which includes a message from Chairman & Chief Executive Officer, Alex Gorsky.

2Q2016 Earnings Infographic

For more information about Johnson & Johnson’s second-quarter 2016 earnings, including full financial data, please read our earnings press release.

Read More

July 18th, 2016

5 Ways Johnson & Johnson Is on the Fast Track to Helping End AIDS

By Hallie Levine

The structure of HIV

The HIV/AIDS crisis first made headlines over three decades ago, but despite the fact that significant strides have been made in treating people with HIV since then, more than one million people still die of AIDS every year.

Over the past 25 years, Johnson & Johnson has remained committed to helping eliminate HIV, from developing six transformational HIV medicines to launching initiatives around the globe to help reduce the burden of HIV in women and children.

But our work is nowhere near done.

In 2014, we launched our Global Public Health (GPH) group, which is focused on addressing unmet health needs around the world. One GPH area of focus is developing holistic, sustainable and measurable solutions to tackle HIV, in partnership with governments and both private and nonprofit organizations.

“We realized that if we were really going to make a difference in HIV-related health outcomes, we needed to do more than develop new products,” says Adrian Thomas, Vice President, Global Programs, Health Impact & Systems Policy, Global Public Health, Johnson & Johnson. “One of our goals is to reduce rates of new infections by 40% in the next two years.”

So as the 2016 International AIDS Conference kicks off in Durban, South Africa, this week, we’re taking a look at the many advances that Johnson & Johnson has made with our HIV efforts—including a preventive HIV vaccine.

Read More

July 15th, 2016

The Quest to Quash Zika: Meet the Brazilian Scientist Working to Develop a Vaccine

By Ginny Graves

With summer’s mosquito season in full swing, and the Rio Olympics fast approaching, concerns over the Zika virus continue to climb—making one Brazilian scientist’s cutting-edge work particularly timely.

Leda Castilho, Ph.D., a professor at the Federal University of Rio De Janeiro’s Alberto Luiz Coimbra Institute of Graduate Studies and Engineering Research, was named the winner of Johnson & Johnson’s Latin American QuickFire Challenge in February for research that her team is currently conducting on Zika—research that has the potential to lead to a vaccine.

Castilho in the lab

The QuickFire Challenge—spearheaded by Johnson & Johnson Innovation, JLABS, in collaboration with pharmaceutical company Janssen Brazil—was created to encourage the development of innovative healthcare technology focused on preventing and eradicating diseases in Latin America.

The challenge’s grand prize? A six-month residency for Castilho and her team at JLABS @ TMC, a state-of-the-art new research facility in Houston, TX, where they will have access to top-notch technology and fellow scientists.

We caught up with Castilho to hear more about her team’s work with the Zika virus—and how their efforts may one day help vanquish it.

What inspired you to enter the QuickFire Challenge?

Leda Castilho: When we heard about it, we knew it was a wonderful opportunity.

Read More

July 14th, 2016

3 Unique Ways Johnson & Johnson Is Making a Difference in the Lives of Mothers and Babies in China

By Ellie Xie, President, Johnson & Johnson Consumer China Ltd.


Ellie Xie with her daughter, Moonlan, and son, Jared

As a new parent, witnessing a baby’s first minute of life is perhaps the most profound and emotional experience possible. I have been lucky enough to have enjoyed this moment twice.

My children are now 15 and 18, but I still remember the initial relief and happiness I felt upon hearing their first cries.

Every new mom should be able to hear that beautiful sound immediately after her baby is born. Unfortunately, that’s not always the case for millions of moms around the world each year.

Birth asphyxia, or inability to breathe at birth, is the leading cause of neonatal mortality worldwide. In fact, 1 in 10 babies have difficulty breathing at birth.

Yet many of these deaths could be prevented using a fairly simple medical procedure known as neonatal resuscitation—it’s just a matter of ensuring that healthcare providers are trained to perform this technique.

RELATED: Baby’s First Breath: How One Landmark Program in China Has Saved the Lives of 150,000 Newborns

Ten Years of Transforming Lives in China
That’s why I was so proud last week to participate in festivities celebrating the 10-year anniversary of the Neonatal Resuscitation Program (NRP) in China—a landmark public-private partnership between Johnson & Johnson, the Chinese Ministry of Health and professional associations based in China and the U.S.

Read More

July 8th, 2016

What Being a Most Powerful Woman Means to Me

By Jane Griffiths, Company Group Chairman, Janssen, the Pharmaceutical Companies of Johnson & Johnson, Europe, Middle East and Africa

Jane Griffiths at the recent
Fortune Most Powerful Women International Summit in London

How would you define “most powerful women”? Is there a secret ingredient to their success?

Questions like these were top of mind at the recent Fortune Most Powerful Women (MPW) International Summit in London, where I was fortunate to be among several women leaders representing Johnson & Johnson.

Attendees were a veritable who’s who of successful leaders from around the world in business, government, media, philanthropy and the arts—and what I learned from them is that there is no one definition or secret ingredient.

Rather, it’s up to every woman to carve out her own place in the world and find a path or focus area that works best for her.

Two Women Driven to Find Value in Purpose
I didn’t have to look far to find two different examples of this in action.

As a speaker in a session titled “Finding Value in Purpose,” I was joined by two very inspirational businesswomen who have gone about their journeys in diverse ways.

Efrat Peled is chairman and CEO of Arison Investments, which creates business investments that combine financial results with sustainable moral responsibility.

Read More